Literature DB >> 15388332

Assembly of nicotinic alpha7 subunits in Xenopus oocytes is partially blocked at the tetramer level.

Annette Nicke1, Heike Thurau, Sven Sadtler, Jürgen Rettinger, Günther Schmalzing.   

Abstract

The assembly of nicotinic alpha1beta1gammadelta, alpha3beta4, and alpha7 receptors and 5-hydroxytryptamine 3A (5HT3A) receptors was comparatively evaluated in Xenopus oocytes by blue native PAGE analysis. While alpha1betagammadelta subunits, alpha3beta4 subunits, and 5HT3A subunits combined efficiently to pentamers, alpha7 subunits existed in various assembly states including trimers, tetramers, pentamers, and aggregates. Only alpha7 subunits that completed the assembly process to homopentamers acquired complex-type carbohydrates and appeared at the cell surface. We conclude that Xenopus oocytes have a limited capacity to guide the assembly of alpha7 subunits, but not 5HT3A subunits to homopentamers. Accordingly, ER retention of imperfectly assembled alpha7 subunits rather than inefficient routing of fully assembled alpha7 receptors to the cell surface limits surface expression levels of alpha7 nicotinic acetylcholine receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15388332     DOI: 10.1016/j.febslet.2004.08.035

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Subtype-specific actions of beta-amyloid peptides on recombinant human neuronal nicotinic acetylcholine receptors (alpha7, alpha4beta2, alpha3beta4) expressed in Xenopus laevis oocytes.

Authors:  Luanda Pym; Mark Kemp; Valérie Raymond-Delpech; Steven Buckingham; C A R Boyd; David Sattelle
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

2.  An intramembrane aromatic network determines pentameric assembly of Cys-loop receptors.

Authors:  Svenja Haeger; Dmitry Kuzmin; Silvia Detro-Dassen; Niklas Lang; Michael Kilb; Victor Tsetlin; Heinrich Betz; Bodo Laube; Günther Schmalzing
Journal:  Nat Struct Mol Biol       Date:  2009-12-20       Impact factor: 15.369

3.  Homodimeric anoctamin-1, but not homodimeric anoctamin-6, is activated by calcium increases mediated by the P2Y1 and P2X7 receptors.

Authors:  Michaela Stolz; Manuela Klapperstück; Thomas Kendzierski; Silvia Detro-Dassen; Anna Panning; Günther Schmalzing; Fritz Markwardt
Journal:  Pflugers Arch       Date:  2015-01-17       Impact factor: 3.657

4.  Mouse RIC-3, an endoplasmic reticulum chaperone, promotes assembly of the alpha7 acetylcholine receptor through a cytoplasmic coiled-coil domain.

Authors:  Ying Wang; Yun Yao; Xiao-Qing Tang; Zuo-Zhong Wang
Journal:  J Neurosci       Date:  2009-10-07       Impact factor: 6.167

Review 5.  Mammalian nicotinic acetylcholine receptors: from structure to function.

Authors:  Edson X Albuquerque; Edna F R Pereira; Manickavasagom Alkondon; Scott W Rogers
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

6.  Differential regulation of alpha7 nicotinic receptor gene (CHRNA7) expression in schizophrenic smokers.

Authors:  Sharon Mexal; Ralph Berger; Judy Logel; Randal G Ross; Robert Freedman; Sherry Leonard
Journal:  J Mol Neurosci       Date:  2009-08-13       Impact factor: 3.444

7.  TMEM16A(a)/anoctamin-1 shares a homodimeric architecture with CLC chloride channels.

Authors:  Ghada Fallah; Thomas Römer; Silvia Detro-Dassen; Ursula Braam; Fritz Markwardt; Günther Schmalzing
Journal:  Mol Cell Proteomics       Date:  2010-10-25       Impact factor: 5.911

Review 8.  Key sites for P2X receptor function and multimerization: overview of mutagenesis studies on a structural basis.

Authors:  Ralf Hausmann; Achim Kless; Gunther Schmalzing
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

9.  Resistance to Inhibitors of Cholinesterase 3 (Ric-3) Expression Promotes Selective Protein Associations with the Human α7-Nicotinic Acetylcholine Receptor Interactome.

Authors:  Matthew J Mulcahy; Sydney B Blattman; Francisco J Barrantes; Ronald J Lukas; Edward Hawrot
Journal:  PLoS One       Date:  2015-08-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.